Levent Savran

Levent Savran

Auto-generated profile, based on publicly available information

Levent Savran

Department of Periodontology, Faculty of Dentistry, Izmir Katip Celebi University, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2017 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
MSM. Sağlam
M. Sağlam
SKS. Köseoğlu
S. Köseoğlu
İTİ. Taşdemir
İ. Taşdemir
HYH. Erbak Yılmaz
H. Erbak Yılmaz
LSL. Savran
L. Savran
RSR. Sütçü
R. Sütçü

2 January 2020 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
DKDiğdem Küçük
Diğdem Küçük
LSLevent Savran
Levent Savran
UEUtku Kürşat Ercan
Utku Kürşat Ercan
ZYZiyşan Buse Yarali
Ziyşan Buse Yarali
OKOzan Karaman
Ozan Karaman
SKSerhat Köseoğlu
Serhat Köseoğlu

30 June 2016 in Odontology
Verified
Journal Article
Closed access
PDF file
MSMehmet Sağlam
Mehmet Sağlam
SKSerhat Köseoğlu
Serhat Köseoğlu
CACüneyt Asım Aral
Cüneyt Asım Aral
LSLevent Savran
Levent Savran
TPTuğba Pekbağrıyanık
Tuğba Pekbağrıyanık
AÇAyşe Çetinkaya
Ayşe Çetinkaya

1 August 2015 in Journal of Periodontology
Verified
Journal Article
Closed access
SKSerhat Köseoğlu
Serhat Köseoğlu
MSMehmet Sağlam
Mehmet Sağlam
TPTuğba Pekbağrıyanık
Tuğba Pekbağrıyanık
LSLevent Savran
Levent Savran
RSRecep Sütçü
Recep Sütçü
Background: A novel member of the interleukin (IL)‐12 family, IL‐35 is an important inhibitory cytokine released by regulatory T cells. The aim of this study is to evaluate gingival crevicular fluid (GCF), saliva, and plasma levels of IL‐35 in periodontal disease and health.Methods: Samples of GCF, whole saliva, and plasma were obtained from systemically healthy, non‐smoking individuals with gingivitis (n = 20) or chronic periodontitis (CP) (n = 20) and periodontally healthy individuals (n = 20). Full‐mouth clinical periodontal measurements, including probing depth (PD), bleeding on probing, gingival index, and plaque index (PI), were also recorded. Enzyme‐linked immunosorbent assay was used to determine IL‐35 levels in the samples. Data were tested statistically by analysis of variance and Pearson rank correlation test.Results: All clinical parameters were significantly higher in the CP group than the healthy and gingivitis groups (P <0.001). The GCF total amount of IL‐35 was significantly higher in the CP group than the other groups (P = 0.04), whereas the GCF concentration of IL‐35 was significantly higher in the healthy group than the other groups (P = 0.002). There were significant differences among the study groups in terms of salivary IL‐35 level (P 0.05). There was a positive correlation between GCF total amount of IL‐35 and PD (r = 0.338, P = 0.03) and PI (r = 0.374, P = 0.005) parameters.Conclusions: IL‐35 could have an important role in suppressing periodontal inflammation and maintaining periodontal health. Additional studies are required to evaluate its role in periodontal diseases.

1 March 2016 in Inflammation
Verified
Journal Article
Closed access
PDF file
CACüneyt Asım Aral
Cüneyt Asım Aral
SKSerhat Köseoğlu
Serhat Köseoğlu
MSMehmet Sağlam
Mehmet Sağlam
TPTuğba Pekbağrıyanık
Tuğba Pekbağrıyanık
LSLevent Savran
Levent Savran

20 July 2024 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
LSLevent Savran
Levent Savran
MSMehmet Sağlam
Mehmet Sağlam
Objectives: Omega-3 supplementation as an adjunct to nonsurgical periodontal treatment has been reported to have a positive effect on healing in periodontitis patients. However, there is a lack of information on the effects of periodontal healing in smokers with periodontitis. The aim of this retrospective study was to investigate the effect of omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment on clinical parameters in smoker and non-smoker periodontitis patients. Methods: This study included a total of 80 periodontitis patients, 40 non-smokers and 40 smokers who were systemically healthy. In this study, patients were divided into 4 groups as follows: Group 1 (Subgingival instrumentation (SI) alone/nonsmoker), Group 2 (SI alone/smoker), Group 3 (SI + Omega-3/nonsmoker) and Group 4 (SI + Omega-3/smoker). Group 3 and 4 consumed 1320 mg Omega-3 capsule (640 mg EPA, 480 mg DHA) once a day for 3 months. Probing depth (PD), clinical attachment level (CAL), gingival index (GI), plaque index (PI) and bleeding on probing (BOP %) were recorded at baseline, 1 month and 3 months after treatment. Results: Significant improvement of all clinical parameters at 1 and 3 months was observed in all groups. Whole mouth CAL, GI and BOP% were significantly reduced in group 4 compared to group 2 at 1 and 3 months postoperatively (p < 0.05). For moderately deep pockets (4–6 mm) and deep pockets (7 mm≤), PD and CAL reductions were significantly greater in groups taking omega − 3 (group 3 and group 4) compared to groups not taking omega-3 (group 1 and group 2) between baseline and 1 month and between baseline and 3 months (p ˂ 0.05). Conclusion: Omega-3 supplementation given as an adjunct to nonsurgical periodontal treatment provided significant benefit in the improvement of clinical parameters (especially for CAL and PD) in the short term in smokers and non-smokers with periodontitis. Clinical relevance: Nonsurgical periodontal treatment with omega-3 supplementation resulted in significant improvements in clinical parameters in smokers and non-smokers with periodontitis.